美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Jyong Biotech Ltd. (Revived IPO)

成交量：- -

成交额：- -

市值：- -

市盈率：- -

高：- -

开：- -

低：- -

收：- -

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Jyong Biotech Ltd. (Revived IPO)

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.healtheverbiotech.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Jyong Biotech Ltd.是一家于2018年1月26日注册成立的开曼群岛豁免公司，主要通过在中国台湾的全资子公司开展业务。健永生技于2002年7月通过Health Ever Bio-Tech Co., Ltd.开始商业运营，该公司自2018年8月以来一直由Jyong Biotech Ltd.全资拥有。健永生技是一家科学驱动型生物技术公司，总部位于中国台湾，致力于开发和商业化创新和差异化新药（植物衍生），主要专注于泌尿系统疾病的治疗，最初的重点是美国、欧盟和亚洲市场。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MENS/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MENS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MENS\",,,,,undefined,":{"symbol":"MENS","market":"US","secType":"STK","nameCN":"Jyong Biotech Ltd. (Revived IPO)","latestPrice":0,"timestamp":1748980800000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":2666667,"shares":76027667,"eps":0,"marketStatus":"已收盘","change":0,"latestTime":"06-03 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1749024000000},"marketStatusCode":5,"adr":0,"listingDate":1744862400000,"exchange":"NASDAQ","adjPreClose":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MENS\",,,,,undefined,":{"symbol":"MENS","floatShares":2666667,"roa":"-17.59%","roe":"--","lyrEps":0,"shares":76027667,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"0.00","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.healtheverbiotech.com","compareEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":0.0458},{"period":"3month","weight":0.0275},{"period":"6month","weight":-0.0246},{"period":"1year","weight":0.1239},{"period":"ytd","weight":0.0113}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jyong Biotech Ltd.是一家于2018年1月26日注册成立的开曼群岛豁免公司，主要通过在中国台湾的全资子公司开展业务。健永生技于2002年7月通过Health Ever Bio-Tech Co., Ltd.开始商业运营，该公司自2018年8月以来一直由Jyong Biotech Ltd.全资拥有。健永生技是一家科学驱动型生物技术公司，总部位于中国台湾，致力于开发和商业化创新和差异化新药（植物衍生），主要专注于泌尿系统疾病的治疗，最初的重点是美国、欧盟和亚洲市场。","exchange":"NASDAQ","name":"Jyong Biotech Ltd. (Revived IPO)","nameEN":"Jyong Biotech Ltd. (Revived IPO)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MENS\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MENS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MENS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MENS\",market:\"US\",delay:false,,,undefined,":{}}}